1.Construction and expression of human anti-HBs-IFN fusion gene
Le JIANG ; Jinqi YAN ; Bingran GUO ; Jie REN ; Jiyun YU
Medical Journal of Chinese People's Liberation Army 1981;0(04):-
Objective To construct eukaryotic expression plasmid pEE14.1-dsFv?pr+,and detect the expression of the recombined gene in eukaryotic CHO-K1 cells.Methods The cationic DNA fragment was cloned into the 3' of VH gene by overlapping extension PCR,and the 6?His tab was inserted to the 3' of VL and human IFN-? gene by the same way.The above mentioned recombinant VH and VL genes were inserted into a pCI-GPI vector first,and then cloned into the pEE14.1 vector to construct the recombinant plasmid pEE14.1-dsFv?pr+.Finally,the recombinant plasmid was transfected into the CHO-K1 cells by LipofectamineTM 2000,and the expression was detected by RT-PCR,ELISA and Western blotting.Results The enzyme digestion and sequencing analysis showed that the recombinant plasmid was successfully constructed.RT-PCR showed that only the cells with transfected plasmid can generate the specific 1700bp fragment.ELISA analysis showed that the production of IFN-?expressed in the supernatant of transfected cells was about 1.1ng/ml.Also,Western blotting could reveal the characteristic band of HBsAg dsFv?pr+ protein.Conclusion The antibody targeting to human IFN-?genes has been successfully expressed in a single open reading frame.Changing the electricity of the antibody may provide the necessary condition for the study of the a new type of anti-HBV drug in nanoscale in the future.
2.Different therapeutic proportion of patients undergone coronary angiography in the era of development in MSCT
Juan DENG ; Wenbin WANG ; Shuoqing HU ; Yue XIAO ; Feng LIANG ; Xuewei GUO ; Haiying WANG ; Pengchuan ZHANG ; Dayi HU ; Tianchang LI ; Chuzhong TANG ; Jiyun WANG ; Changlin LU
Journal of Geriatric Cardiology 2008;5(2):83-85
Objective To study the different therapeutic proportion of the patient populations undergone coronary angiography (CAG) in the era of development in multislice spiral computed tomography(MSCT).Methods Two hundred and fifty four consecutive patients(mean age 59.24±10.65),who underwent CAG at Daxing Hospital from February 2007 through October 2007,were enrolled,160 patients were male and 94 were female.By evaluating from the coronary angiogram,the patients were not diagnosed to have coronary heart disease(CHD) with less than 50% diameter stenosis of coronary artery;the patients to have CHD with more than or equal to 50% stenosis of coronary artery;the patients were performed the procedure of percutaneous coronary intervention(PCI) with more than or equal to 70% stenosis;the patients were proposed to have coronary aortic bypass graft(CABG) surgery with left main coronary artery lesions or diffuse triple coronary artery lesions.Results In the 254 consecutive patients,59 patients(23.2%) had not been diagnosed to have CHD;195(76.8%)to have CHD,of these patients with CHD,49 patients(19.3%)were not indicated for PCI (including the patients receiving follow-up coronary angiography after stenting),81(31.9%)had been performed the procedure of stent implantation,57(22.4%)proposed to have CABG,8(3.1%)the procedure of PCI had not been successful,or had not been performed because of patients opposing to this therapy.Conclusion Multislice spiral computed tomography can be applied as a non-invasive screening tool to exclude the presence of CHD,to increase the positive proportion of the populations with CHD in all patients receiving coronary angiograhpy,to avoid the use of CAG in a subset of patients.
3.Value of C-TIRADS classification combined with SWE and SMI in the diagnosis of thyroid malignant nodules
Jiyun GUO ; Rui MA ; Yingyun WU ; Guiduan HE ; Liangyu WANG
Chinese Journal of Endocrine Surgery 2024;18(3):388-392
Objective:To analyze the Chinese thyroid imaging reporting and data system (C-TIRADS) classification combined with ultrasonic shear wave elastography (SWE) and super microvascular imaging technology (SMI) in the diagnosis of benign and malignant thyroid nodules.Methods:Clinical data of 125 patients undergoing thyroid nodule surgery in the Department of Ultrasound Medicine, Shantou Central Hospital were retrospectively analyzed. There were 35 males and 90 females. The disease duration was (3.45±1.32) years, ranging from 3 months to 7 years; the age was (55.45±3.31) years old, ranging from 25 to 70 years old; the maximum diameter of the nodule is (12.13±5.76) mm, ranging from 5.0 to 42.9 mm. C-TIRADS classification, SWE, SMI and pathological diagnosis results of ultrasonic nodules in patients were analyzed. The diagnostic performance of C-TIRADS classification, SWE, SMI and combined diagnosis of malignant nodules were analyzed. SPSS 21.0 software was used to analyze the data, and the measurement data were consistent with the normal Statistical distribution, independent t test was performed for comparison between two groups; count data were expressed as rate (%), and χ2 test was used. Results:A total of 180 lesions were detected this time. According to pathological diagnosis, there were 114 benign nodules and 66 malignant nodules; the malignant percentage of C-TIRADS 4B nodules was the highest, reaching 72.00% (36/50) ; Emix of malignant nodules, Emax and Emean were (15.98±6.56) kPa, (84.22±24.23) kPa and (63.29±15.89) kPa respectively, which were significantly higher than those of benign nodules (13.56±4.68) kPa, (48.33±14.46) kPa and (37.32±12.63kPa) ( t=2.49, 8.76, 9.07, P<0.05) ; Type IV malignancy accounted for the highest proportion in SMI classification of thyroid nodules, which was 78.95%; the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the joint diagnosis were 94.64%, 92.85%, 94.64%, 42.85%, 90.16%, higher than the single C-TIRADS classification (89.65%, 75.00%, 89.65%, 37.50%, 80.55%), SMI (82.35%, 55.56%, 89.36%, 32.60%, 78.33%), and SWE diagnosis (81.08%, 56.00%, 90.22%, 28.57%, 77.22%). The difference was statistically significant ( P<0.05) . Conclusions:Compared with the diagnostic efficiency of SWE, SMI and C-TIRADS classification alone, the combined use of the three has higher diagnostic efficiency for benign and malignant thyroid nodules. The abuse of invasive procedures can be reduced or avoided.
4.Analysis of Carotid Artery Elasticity and Influencing Factors in the Offspring of Early-Onset Type 2 Diabetes Mellitus by RF-Data Based Quantitative Analysis on Vessel Stiffness
Jiyun CHEN ; Yanyan GUO ; Jianjun YUAN ; Xijun ZHANG ; Ming WU ; Haohui ZHU
Chinese Journal of Medical Imaging 2024;32(9):897-902
Purpose To evaluate the carotid artery elasticity and the influencing factors in the offspring of early-onset type 2 diabetes mellitus by RF-data based quantitative analysis on vessel stiffness.Materials and Methods We continuously encrolled 63 offspring of type 2 diabetes mellitus,depending on the parental diagnostic age of diabetes they were divided into two groups:32 cases of early-onset offspring group,31 cases of late-onset offspring group.32 healthy volunteers who were matched for age,gender and body mass index,were selected as controls.Real-time intima-media thickness and RF-data based quantitative analysis on vessel stiffness were employed to evaluate common carotid intima-media thickness,displacement,diameter,hardness coefficient and pulse wave velocity.The differences among the groups were compared.Results The intima-media thickness,pulse wave velocity and hardness coefficient in early-onset offspring group were higher than late-onset offspring group(t=0.054-1.228,P<0.05),and displacement was lower than late-onset offspring group(t=0.048,0.109,both P<0.05).Conclusion Carotid artery stiffness in the offspring of diabetes mellitus patients is significantly higher than the control group.And the carotid elasticity of early-onset offspring group decreased more obviously than late-onset group.
5.Clinical values of laboratory inflammation indicators for diagnosis and treatment of COVID-19 patients
Dagang WANG ; Weijie LI ; Fangfang JIN ; Shuang WANG ; Jiyun SUN ; Chun ZHOU ; Fei XU ; Jingjing GUO ; Yajie WANG
Chinese Journal of Experimental and Clinical Virology 2020;34(4):347-351
Objective:To investigate the clinical values of laboratory inflammation indicators including lymphocyte count, C reactive protein (CRP), serum amyloid A protein (SAA), and procalcitonin (PCT) in the diagnosis and treatment of 2019 novel corona virus disease (COVID-19) patients.Methods:The data of clinical characteristics of 77 hospitalized COVID-19 patients were collected from February to March 2020. According to the guidelines for diagnosis and management of COVID-19, these patients were divided into moderate type (49 cases) and severe type (28 cases). Among them 19 cases were discharged. The differences of lymphocyte count, CRP, SAA and PCT among moderate, severe and discharged groups were compared. The indicators with better predictive value for disease development and prognosis were screened out by logistic regression and receiver operating characteristic curve (ROC) analysis.Results:The severe patients had lower lymphocyte count compared to the moderate patients ( P=0.000), while their CRP ( P=0.000), SAA ( P=0.000) and PCT positive rate ( χ2=11.003, P=0.001) were significantly higher; The lymphocyte count of discharged patients was much higher than that of moderate ( P=0.001) and severe ( P=0.000) patients, while CRP ( P=0.036, P=0.000) and SAA ( P=0.002, P=0.000) were dramatically lower; Although the discharged patients had much lower PCT positive rate than severe patients ( χ2=6.891, P=0.009), they were not significantly different from moderate patients ( χ2=0.169, P=0.681). Logistic regression analysis showed that the increased SAA and CRP were both risk factors for predicting severe illness, but the decreased SAA were demonstrated as an independent indicator for discharge. The ROC curve analysis showed that the sensitivity and specificity of SAA for diagnosis of severe patients were 85.71% and 87.76%, whereas CRP were 82.14% and 93.88%. Further, the sensitivity and specificity of SAA for predicting discharge were 100% and 57.89%. Conclusions:The laboratory inflammation indicators such as lymphocyte count, CRP, SAA and PCT had important clinical significance for the diagnosis and treatment of COVID-19 patients. Among them, SAA was demonstrated as an independent indicator with high sensitivity for evaluating the disease progression and prognosis.